Last updated 2026-07-20
- Raised Seed round led by Prof. Nava & Yehuda Zisapel, Dec 1999
Total raised
—
Last: Undisclosed Round 2000-01
Stage
Mature
Founded
1991
Headcount
34
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Neurim Pharmaceuticals is a neuroscience drug discovery and development company established in 1991 by renowned neuroscientist Nava Zisapel and high-tech entrepreneur Yehuda Zisapel. The company focuses on discovering and developing new medicines for disorders related to the central nervous system (CNS), aiming to improve people's lives through constant innovation. Their mission emphasizes pioneering research, strategic partnerships, and addressing unmet needs in CNS disease management. Neurim has a proven track record of drug development and commercialization, with products like Circadin® and Slenyto® marketed in over 40 countries. The R&D pipeline includes new products addressing insomnia, Alzheimer's dementia, and sleep apnea.
Funding history · 1 round · — total
1999-12
Seed
Undisclosed
★ Prof. Nava & Yehuda Zisapel
Headcount over time
From 20 (2018-09) to 20 (2026-01) · +0 (+0%) · 28 points · source: Finder history + radar grounding
Q&A
- What is Neurim Pharmaceuticals' primary focus?
- Neurim Pharmaceuticals is a drug discovery and development company focused on creating drugs for brain restoration and ongoing support, addressing insomnia, central nervous system problems, and neurodegenerative diseases.
- What is Neurim Pharmaceuticals' first approved drug?
- Neurim Pharmaceuticals' first approved drug is Circadin, a timed-release melatonin for insomnia, which is commercially available in Europe, the AsiaPacific region, and the Middle East.
- Has Neurim Pharmaceuticals received any recent marketing authorization recommendations for its products?
- Yes, the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended marketing authorization for Slenyto, a pediatric prolonged-release melatonin-coated tablet formulation for the treatment of children and adolescents with autism spectrum disorder and/or Smith-Magenis syndrome who suffer from insomnia.
- Where is Neurim Pharmaceuticals headquartered?
- Neurim Pharmaceuticals is headquartered in Tel Aviv-Yafo, Israel, with an additional office in Zug, Switzerland.
- When was Neurim Pharmaceuticals founded?
- Neurim Pharmaceuticals was founded in June 1991.
- Who is a co-founder of Neurim Pharmaceuticals?
- Nava Zisapel is a Co-Founder and CSO of Neurim Pharmaceuticals.
- What is the employee count for Neurim Pharmaceuticals?
- Neurim Pharmaceuticals has 11-50 employees.
- What is Neurim Pharmaceuticals' primary sector?
- Neurim Pharmaceuticals' primary sector is Health Tech & Life Sciences.
Team · 2
Nava Zisapel
Founder · Co-Founder & CEO
Yehuda Zisapel
Founder · Co-Founder & President
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue Engineering
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B
Highlights
1 Patents
Tags
neurologydegenerative-diseasesdrug-discoverysleep-disordersalzheimers-diseasepharmaceuticalscns-disorderspatientspharma-companiesbiopharmaceuticalseniors
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | neurim.com |
|---|---|
| linkedin.com/company/1268772 | |
| Wikidata | wikidata.org/wiki/Q43896242 |
Identifiers & details
| Legal name | Neurim Pharmaceuticals Ltd. |
|---|---|
| Founded | 1991 |
| Employees (exact) | 34 |
| Offices | Zug |
| Wikidata QID | Q43896242 |
Radar intelligence
Patents
| EPO | 46 |
|---|
Web history (Wayback)
| Domain | neurim.com |
|---|
Wikidata
| QID | Q43896242 |
|---|
Certificate / subdomain footprint
| Subdomains | 10 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512705203 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1991-12-04 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | הברזל 27 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-15 | דו~ח שנתי |